These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19583)

  • 1. Potentiation by reserpine of the inhibition by amphetamine of (3H)dopamine accumulation in the rat striatum.
    Ross SB
    J Pharm Pharmacol; 1977 Jul; 29(7):433-4. PubMed ID: 19583
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):328-36. PubMed ID: 581027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.
    Del Rio J; Madroñal J
    Eur J Pharmacol; 1976 Oct; 39(2):267-74. PubMed ID: 976322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]dopamine depletion from osmotically defined storage sites: effects of reserpine, 53 mM KCl, and d-amphetamine.
    Takimoto GS; Stittsworth JD; Stephens JK
    J Neurochem; 1983 Jul; 41(1):119-27. PubMed ID: 6864214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 8. One injection of cocaine produces a long-lasting increase in [3H]-dopamine release.
    Peris J; Zahniser NR
    Pharmacol Biochem Behav; 1987 Jul; 27(3):533-5. PubMed ID: 3659076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by d-amphetamine of the electrically evoked release of [3H]acetylcholine from slices of the rat striatum: involvement of dopamine receptors.
    Cantrill RC; Arbilla S; Langer SZ
    Eur J Pharmacol; 1983 Jan; 87(1):167-8. PubMed ID: 6840186
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum.
    Ross SB; Kelder D
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):329-35. PubMed ID: 474143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phencyclidine-induced release of [3H]dopamine from chopped striatal tissue.
    Ary TE; Komiskey HL
    Neuropharmacology; 1982 Jul; 21(7):639-45. PubMed ID: 7121737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 14. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
    Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
    Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for carrier-mediated efflux of dopamine from corpus striatum.
    Liang NY; Rutledge CO
    Biochem Pharmacol; 1982 Aug; 31(15):2479-84. PubMed ID: 7126258
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of psychotropic drugs on the distribution of 3H-dopamine into compartments of rat striatal synaptosomes and on subsequent depolarization-induced 3H-dopamine release.
    de Langen CD; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):169-77. PubMed ID: 7383166
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium-independent release of [3H]dopamine by veratridine in pargyline- and reserpine-treated corpus striatum.
    Liang NY; Rutledge CO
    Eur J Pharmacol; 1983 Apr; 89(1-2):153-5. PubMed ID: 6861884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis.
    Kuczenski R; Segal DS
    Eur J Pharmacol; 1975 Feb; 30(2):244-51. PubMed ID: 1126362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine.
    Watanabe S; Aono Y; Fusa K; Takada K; Saigusa T; Koshikawa N; Cools AR
    Neuroscience; 2005; 136(1):251-7. PubMed ID: 16181742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.